Antipsychotic Long-acting Injections by Peter HaddadAntipsychotic Long-acting Injections by Peter Haddad

Antipsychotic Long-acting Injections

EditorPeter Haddad, Tim Lambert, John Lauriello

Paperback | April 23, 2016

Pricing and Purchase Info


Earn 368 plum® points

Prices and offers may vary in store


Ships within 1-2 weeks

Ships free on orders over $25

Not available in stores


Antipsychotic Long-acting Injections (LAIs) were introduced in the 1960s to improve treatment adherence in schizophrenia. Subsequently, first-generation antipsychotic LAIs became widely used in many countries. Since the initial publication of Antipsychotic Long-acting Injections in 2010, newtrial data have been published on long-acting injection (LAI) preparations of the drugs Risperidone, Paliperidone, and Olanzapine. Furthermore, a new LAI preparation of the drug Aripiprazole has recently been approved for clinical use in the United States and is likely to be approved in Europe soon.The second edition of this successful book has been fully updated to include this new data, with reference to both observational studies and randomized controlled trials, as well as other new developments in the clinical use of antipsychotic LAIs. New chapters have been added covering the comparisonbetween oral and injectable antipsychotics, Olanzapine LAI, Aripiprazole LAI, and the practicalities of organizing a specialized clinic for long-acting injectable antipsychotics. Existing chapters have also been thoroughly updated to take into account the most recently published research. Antipsychotic Long-acting Injections, Second edition brings together clinical and research findings on LAIs in a comprehensive volume, with chapters written by international experts.
Dr Peter Haddad is Consultant Psychiatrist at Greater Manchester West Mental Health NHS Foundation Trust, UK and Honorary Clinical Professor of Psychiatry at the University of Manchester, UK. He has a major clinical and research interest in pharmacological treatment of major mental illnesses (depression, bipolar disorder, schizophrenia...
Title:Antipsychotic Long-acting InjectionsFormat:PaperbackDimensions:384 pages, 9.21 × 6.14 × 0 inPublished:April 23, 2016Publisher:Oxford University PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0198729472

ISBN - 13:9780198729471

Look for similar items by category:


Table of Contents

1. Christoph U. Correll, Chris Abbott, Samuel J. Keith, and Peter Haddad: Antipsychotic treatment and adherence in schizophrenia2. Tim Lambert and David Taylor: Pharmacology of antipsychotic long-acting injections3. Peter Haddad and W. Wolfgang Fleischhacker: Adverse effects and antipsychotic long-acting injections4. Taishiro Kishimoto, Christoph U. Correll, and John M. Kane: Comparative effectiveness of oral antipsychotics and Long-acting Injectable Antipsychotics5. Mark Taylor and Polash Shajahan: First-generation antipsychotic long-acting injections6. Pierre Chue: Risperidone Long-acting Injection7. Muaid Ithman, Niels Beck, and John Lauriello: Paliperidone Long-Acting Injection8. Dieter Naber, Daniel Luedecke, and Daniel Schottle: Olanzapine long-acting injection9. Ganesh Gopalakrishna, W. Wolfgang Fleischhacker, and John Lauriello: Aripiprazole Long Acting Injectable10. Robin Emsley, Bonga Chiliza, and Laila Asmal: Long-acting injectable antipsychotics in early psychosis11. Maxine X. Patel: Health professionals' and patients' attitudes to LAIs12. Mary Jane Tacchi, Jennifer Nendick, and Jan Scott: Patient choice and long-acting injectable medication13. Tim Lambert: Prescribing patterns and determinants of use of antipsychotic long-acting injections: an international perspective14. Tim Lambert: The management of a specialist clinic for long acting injectable antipsychotics15. Peter Haddad, Tim Lambert, and John Lauriello: The role of antipsychotic long-acting injections in clinical practice